Mark Lambrecht (moderator)
Senior Director, Global Health and Life Sciences, SAS
About the webinar
AI is rapidly reshaping the health and life sciences industry – driving new possibilities in research, development, operations and patient engagement. But as capabilities expand, so does the need for thoughtful governance.
In this webinar, you’ll gain a practical understanding of how agentic AI and generative AI are delivering value today, and how governance frameworks are evolving to ensure these technologies are applied ethically, responsibly and in alignment with industry regulations.
Learn more about:
- How agentic AI supports care coordination, clinical decision support, trial optimization, drug discovery, supply chain logistics and more.
- How generative AI drives process automation, alleviates documentation burden, transforms drug development and enhances patient communication.
- Best practices in AI governance to build ethical, responsible and compliant AI systems.
Have a SAS profile? To complete this form automatically Sign In
About the experts
Nicoleta Economou-Zavlanos, PhD
Director, AI Evaluation & Governance, Duke Health
Parag Limaye
Managing Director, Deloitte
Andrea Beccari
Vice President EXSCALATE, Dompé Farmaceutici